IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice

BackgroundCardiac dysfunction is one of the most common complications of sepsis and is associated with the adverse outcomes and high mortality of sepsis patients. IL-12p40, the common subunit of IL-12 and IL-23, has been shown to be involved in a variety of inflammation-related diseases, such as pso...

Full description

Bibliographic Details
Main Authors: Menglin Liu, Zhen Wang, Jishou Zhang, Di Ye, Menglong Wang, Yao Xu, Mengmeng Zhao, Yongqi Feng, Xiyi Lu, Heng Pan, Wei Pan, Cheng Wei, Dan Tian, Wenqiang Li, Jingjun Lyu, Jing Ye, Jun Wan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.950029/full
_version_ 1811183554086830080
author Menglin Liu
Zhen Wang
Jishou Zhang
Di Ye
Menglong Wang
Yao Xu
Mengmeng Zhao
Yongqi Feng
Xiyi Lu
Heng Pan
Wei Pan
Cheng Wei
Dan Tian
Wenqiang Li
Jingjun Lyu
Jing Ye
Jun Wan
author_facet Menglin Liu
Zhen Wang
Jishou Zhang
Di Ye
Menglong Wang
Yao Xu
Mengmeng Zhao
Yongqi Feng
Xiyi Lu
Heng Pan
Wei Pan
Cheng Wei
Dan Tian
Wenqiang Li
Jingjun Lyu
Jing Ye
Jun Wan
author_sort Menglin Liu
collection DOAJ
description BackgroundCardiac dysfunction is one of the most common complications of sepsis and is associated with the adverse outcomes and high mortality of sepsis patients. IL-12p40, the common subunit of IL-12 and IL-23, has been shown to be involved in a variety of inflammation-related diseases, such as psoriasis and inflammatory bowel disease. However, the role of IL-12p40 in lipopolysaccharide (LPS)-induced cardiac dysfunction remains obscure. This study aimed to explore the role of IL-12p40 in LPS-induced cardiac dysfunction and its potential mechanisms.MethodsIn this study, mice were treated with LPS and the cardiac expression of IL-12p40 was determined. Then, IL-12p40–/– mice were used to detect the role and mechanisms of IL-12p40 in LPS-induced cardiac injury. In addition, monocytes were adoptively transferred to IL-12p40–/– mice to explore their effects on LPS-induced cardiac dysfunction.ResultsThe results showed that cardiac IL-12p40 expression was significantly increased after treated with LPS. In addition, IL-12p40 deletion significantly aggravated LPS-induced cardiac dysfunction, evidenced by the increased serum levels of cardiomyocyte injury markers and heart injury scores, as well as by the deteriorated cardiac function. Moreover, IL-12p40 deletion increased LPS-induced monocyte accumulation and cardiac expression of inflammatory cytokines, as well as enhanced the activation of the NF-κB and MAPK pathways. Furthermore, adoptive transfer WT mouse monocytes to IL-12p40−/− mice alleviated LPS-induced cardiac dysfunction and decreased the phosphorylation of p65.ConclusionIL-12p40 deletion significantly aggravated LPS-induced cardiac injury and cardiac dysfunction in mice by regulating the NF-κB and MAPK signaling pathways, and this process was related to monocytes. Therefore, IL-12p40 show a protective role in SIC, and IL-12p40 deficiency or anti-IL-12p40 monoclonal antibodies may be detrimental to patients with SIC.
first_indexed 2024-04-11T09:48:42Z
format Article
id doaj.art-79f9b33812fb425ca5a03badc1cb05d0
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T09:48:42Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-79f9b33812fb425ca5a03badc1cb05d02022-12-22T04:30:53ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-09-01910.3389/fcvm.2022.950029950029IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in miceMenglin Liu0Zhen Wang1Jishou Zhang2Di Ye3Menglong Wang4Yao Xu5Mengmeng Zhao6Yongqi Feng7Xiyi Lu8Heng Pan9Wei Pan10Cheng Wei11Dan Tian12Wenqiang Li13Jingjun Lyu14Jing Ye15Jun Wan16Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Emergency, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Emergency, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Emergency, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, ChinaBackgroundCardiac dysfunction is one of the most common complications of sepsis and is associated with the adverse outcomes and high mortality of sepsis patients. IL-12p40, the common subunit of IL-12 and IL-23, has been shown to be involved in a variety of inflammation-related diseases, such as psoriasis and inflammatory bowel disease. However, the role of IL-12p40 in lipopolysaccharide (LPS)-induced cardiac dysfunction remains obscure. This study aimed to explore the role of IL-12p40 in LPS-induced cardiac dysfunction and its potential mechanisms.MethodsIn this study, mice were treated with LPS and the cardiac expression of IL-12p40 was determined. Then, IL-12p40–/– mice were used to detect the role and mechanisms of IL-12p40 in LPS-induced cardiac injury. In addition, monocytes were adoptively transferred to IL-12p40–/– mice to explore their effects on LPS-induced cardiac dysfunction.ResultsThe results showed that cardiac IL-12p40 expression was significantly increased after treated with LPS. In addition, IL-12p40 deletion significantly aggravated LPS-induced cardiac dysfunction, evidenced by the increased serum levels of cardiomyocyte injury markers and heart injury scores, as well as by the deteriorated cardiac function. Moreover, IL-12p40 deletion increased LPS-induced monocyte accumulation and cardiac expression of inflammatory cytokines, as well as enhanced the activation of the NF-κB and MAPK pathways. Furthermore, adoptive transfer WT mouse monocytes to IL-12p40−/− mice alleviated LPS-induced cardiac dysfunction and decreased the phosphorylation of p65.ConclusionIL-12p40 deletion significantly aggravated LPS-induced cardiac injury and cardiac dysfunction in mice by regulating the NF-κB and MAPK signaling pathways, and this process was related to monocytes. Therefore, IL-12p40 show a protective role in SIC, and IL-12p40 deficiency or anti-IL-12p40 monoclonal antibodies may be detrimental to patients with SIC.https://www.frontiersin.org/articles/10.3389/fcvm.2022.950029/fullsepsisIL-12p40 deletioncardiac dysfunctionmonocytesLPS
spellingShingle Menglin Liu
Zhen Wang
Jishou Zhang
Di Ye
Menglong Wang
Yao Xu
Mengmeng Zhao
Yongqi Feng
Xiyi Lu
Heng Pan
Wei Pan
Cheng Wei
Dan Tian
Wenqiang Li
Jingjun Lyu
Jing Ye
Jun Wan
IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
Frontiers in Cardiovascular Medicine
sepsis
IL-12p40 deletion
cardiac dysfunction
monocytes
LPS
title IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
title_full IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
title_fullStr IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
title_full_unstemmed IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
title_short IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
title_sort il 12p40 deletion aggravates lipopolysaccharide induced cardiac dysfunction in mice
topic sepsis
IL-12p40 deletion
cardiac dysfunction
monocytes
LPS
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.950029/full
work_keys_str_mv AT menglinliu il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT zhenwang il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT jishouzhang il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT diye il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT menglongwang il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT yaoxu il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT mengmengzhao il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT yongqifeng il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT xiyilu il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT hengpan il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT weipan il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT chengwei il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT dantian il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT wenqiangli il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT jingjunlyu il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT jingye il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice
AT junwan il12p40deletionaggravateslipopolysaccharideinducedcardiacdysfunctioninmice